174 related articles for article (PubMed ID: 26469964)
1. Stressing out the Hippo/YAP signaling pathway: toward a new role in Schwann cells.
Melfi S; Colciago A; Giannotti G; Bonalume V; Caffino L; Fumagalli F; Magnaghi V
Cell Death Dis; 2015 Oct; 6(10):e1915. PubMed ID: 26469964
[No Abstract] [Full Text] [Related]
2. YAP and TAZ: a nexus for Hippo signaling and beyond.
Hansen CG; Moroishi T; Guan KL
Trends Cell Biol; 2015 Sep; 25(9):499-513. PubMed ID: 26045258
[TBL] [Abstract][Full Text] [Related]
3. The role of Hippo signaling in tooth development.
Li CH; Li CZ
J Formos Med Assoc; 2016 May; 115(5):295-7. PubMed ID: 25890496
[No Abstract] [Full Text] [Related]
4. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
[TBL] [Abstract][Full Text] [Related]
5. [The world according to YAP: a continuous cross-talk between Wnt and Hippo pathways].
Gilgenkrantz H
Med Sci (Paris); 2013 Oct; 29(10):868-74. PubMed ID: 24148125
[TBL] [Abstract][Full Text] [Related]
6. The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease.
He J; Bao Q; Yan M; Liang J; Zhu Y; Wang C; Ai D
Br J Pharmacol; 2018 Apr; 175(8):1354-1361. PubMed ID: 28369744
[TBL] [Abstract][Full Text] [Related]
7. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas.
Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H
J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373
[TBL] [Abstract][Full Text] [Related]
9. Hippo signaling maintains the phenotype of pancreatic acinar cells.
Sosa-Pineda B
Gastroenterology; 2013 Jun; 144(7):1345-8. PubMed ID: 23623964
[No Abstract] [Full Text] [Related]
10. Hippo pathway regulation of gastrointestinal tissues.
Yu FX; Meng Z; Plouffe SW; Guan KL
Annu Rev Physiol; 2015; 77():201-27. PubMed ID: 25293527
[TBL] [Abstract][Full Text] [Related]
11. Hippo signaling in the kidney: the good and the bad.
Wong JS; Meliambro K; Ray J; Campbell KN
Am J Physiol Renal Physiol; 2016 Aug; 311(2):F241-8. PubMed ID: 27194720
[TBL] [Abstract][Full Text] [Related]
12. The Crosstalk Between Hippo-YAP Pathway and Innate Immunity.
Wang S; Zhou L; Ling L; Meng X; Chu F; Zhang S; Zhou F
Front Immunol; 2020; 11():323. PubMed ID: 32174922
[TBL] [Abstract][Full Text] [Related]
13. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas.
Gao T; Zhou D; Yang C; Singh T; Penzo-Méndez A; Maddipati R; Tzatsos A; Bardeesy N; Avruch J; Stanger BZ
Gastroenterology; 2013 Jun; 144(7):1543-53, 1553.e1. PubMed ID: 23454691
[TBL] [Abstract][Full Text] [Related]
14. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation.
Mannaerts I; Leite SB; Verhulst S; Claerhout S; Eysackers N; Thoen LF; Hoorens A; Reynaert H; Halder G; van Grunsven LA
J Hepatol; 2015 Sep; 63(3):679-88. PubMed ID: 25908270
[TBL] [Abstract][Full Text] [Related]
15. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies.
Werneburg N; Gores GJ; Smoot RL
Gene Expr; 2020 Jun; 20(1):67-74. PubMed ID: 31253203
[TBL] [Abstract][Full Text] [Related]
16. YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis.
Guerrant W; Kota S; Troutman S; Mandati V; Fallahi M; Stemmer-Rachamimov A; Kissil JL
Cancer Res; 2016 Jun; 76(12):3507-19. PubMed ID: 27216189
[TBL] [Abstract][Full Text] [Related]
17. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
Zhi X; Zhao D; Zhou Z; Liu R; Chen C
Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
[TBL] [Abstract][Full Text] [Related]
18. Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.
Wu LMN; Deng Y; Wang J; Zhao C; Wang J; Rao R; Xu L; Zhou W; Choi K; Rizvi TA; Remke M; Rubin JB; Johnson RL; Carroll TJ; Stemmer-Rachamimov AO; Wu J; Zheng Y; Xin M; Ratner N; Lu QR
Cancer Cell; 2018 Feb; 33(2):292-308.e7. PubMed ID: 29438698
[TBL] [Abstract][Full Text] [Related]
19. The Hippo Pathway in Prostate Cancer.
Salem O; Hansen CG
Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
[TBL] [Abstract][Full Text] [Related]
20. Beyond the Cardiomyocyte: Consideration of HIPPO Pathway Cell-Type Specificity.
Del Re DP
Circ Res; 2018 Jun; 123(1):30-32. PubMed ID: 29929975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
